Cargando…
Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment
Malignant gliomas are heterogeneous diseases in genetic basis. The development of sequencing techniques has identified many gene rearrangements encoding novel oncogenic fusions in malignant glioma to date. Understanding the gene fusions and how they regulate cellular processes in different subtypes...
Autores principales: | Xu, Tao, Wang, Hongxiang, Huang, Xiaoquan, Li, Weiqing, Huang, Qilin, Yan, Yong, Chen, Juxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071515/ https://www.ncbi.nlm.nih.gov/pubmed/29571074 http://dx.doi.org/10.1016/j.tranon.2018.02.020 |
Ejemplares similares
-
The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas()
por: Wang, Hongxiang, et al.
Publicado: (2015) -
Identification of CDKL3 as a critical regulator in development of glioma through regulating RRM2 and the JNK signaling pathway
por: Cui, Yong, et al.
Publicado: (2021) -
MicroRNA-326 Functions as a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1)
por: Zhou, Jingxu, et al.
Publicado: (2013) -
Glioma-neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review)
por: Hua, Tianzhen, et al.
Publicado: (2022) -
Impact of General Factors on Glioma Immunotherapy
por: Huang, Qilin, et al.
Publicado: (2022)